Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Between-region genetic divergence reflects the mode and tempo of tumor evolution

Nature Genetics volume 49, pages 1015–1024 (2017)Cite this article

Subjects

Abstract

Given the implications of tumor dynamics for precision medicine, there is a need to systematically characterize the mode of evolution across diverse solid tumor types. In particular, methods to infer the role of natural selection within established human tumors are lacking. By simulating spatial tumor growth under different evolutionary modes and examining patterns of between-region subclonal genetic divergence from multiregion sequencing (MRS) data, we demonstrate that it is feasible to distinguish tumors driven by strong positive subclonal selection from those evolving neutrally or under weak selection, as the latter fail to dramatically alter subclonal composition. We developed a classifier based on measures of between-region subclonal genetic divergence and projected patient data into model space, finding different modes of evolution both within and between solid tumor types. Our findings have broad implications for how human tumors progress, how they accumulate intratumoral heterogeneity, and ultimately how they may be more effectively treated.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Overview of the simulation framework and the genomic data analysis pipeline.
Figure 2: Characteristics of virtual tumors simulated under different modes of evolution.
Figure 3: Colorectal tumors exhibit patterns of between-region genetic divergence consistent with effectively neutral growth or selection.
Figure 4: Single-gland WES shows spatial constraints among subclonal mutations.
Figure 5: The SFS reflects differential modes of evolution within and between tumor types.
Figure 6: Projection of patient samples onto distinct evolutionary modes.

Similar content being viewed by others

Accession codes

Primary accessions

ArrayExpress

References

  1. Nordling, C.O. A new theory on cancer-inducing mechanism. Br. J. Cancer 7, 68–72 (1953).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Armitage, P. & Doll, R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br. J. Cancer 8, 1–12 (1954).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Nowell, P.C. The clonal evolution of tumor cell populations. Science 194, 23–28 (1976).

    Article  CAS  PubMed  Google Scholar 

  4. Cairns, J. Mutation selection and the natural history of cancer. Nature 255, 197–200 (1975).

    Article  CAS  PubMed  Google Scholar 

  5. Fearon, E.R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759–767 (1990).

    Article  CAS  PubMed  Google Scholar 

  6. Tsao, J.L. et al. Genetic reconstruction of individual colorectal tumor histories. Proc. Natl. Acad. Sci. USA 97, 1236–1241 (2000).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Tomasetti, C., Vogelstein, B. & Parmigiani, G. Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation. Proc. Natl. Acad. Sci. USA 110, 1999–2004 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Hu, Z., Sun, R. & Curtis, C. A population genetics perspective on the determinants of intra-tumor heterogeneity. Biochim. Biophys. Acta http://dx.doi.org/10.1016/j.bbcan.2017.03.001 (2017).

  9. Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546–1558 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Nik-Zainal, S. et al. The life history of 21 breast cancers. Cell 149, 994–1007 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Fischer, A., Vázquez-García, I., Illingworth, C.J. & Mustonen, V. High-definition reconstruction of clonal composition in cancer. Cell Reports 7, 1740–1752 (2014).

    Article  CAS  PubMed  Google Scholar 

  12. Roth, A. et al. PyClone: statistical inference of clonal population structure in cancer. Nat. Methods 11, 396–398 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Miller, C.A. et al. SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution. PLOS Comput. Biol. 10, e1003665 (2014).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Deshwar, A.G. et al. PhyloWGS: reconstructing subclonal composition and evolution from whole-genome sequencing of tumors. Genome Biol. 16, 35 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  15. Sottoriva, A. et al. A Big Bang model of human colorectal tumor growth. Nat. Genet. 47, 209–216 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Uchi, R. et al. Integrated multiregional analysis proposing a new model of colorectal cancer evolution. PLoS Genet. 12, e1005778 (2016).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Sievers, C.K. et al. Subclonal diversity arises early even in small colorectal tumours and contributes to differential growth fates. Gut http://dx.doi.org/10.1136/gutjnl-2016-312232 (2016).

  18. Bozic, I., Gerold, J.M. & Nowak, M.A. Quantifying clonal and subclonal passenger mutations in cancer evolution. PLOS Comput. Biol. 12, e1004731 (2016).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Suzuki, Y. et al. Multiregion ultra-deep sequencing reveals early intermixing and variable levels of intratumoral heterogeneity in colorectal cancer. Mol. Oncol. 11, 124–139 (2017).

    Article  CAS  PubMed  Google Scholar 

  20. Ling, S. et al. Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution. Proc. Natl. Acad. Sci. USA 112, E6496–E6505 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Williams, M.J., Werner, B., Barnes, C.P., Graham, T.A. & Sottoriva, A. Identification of neutral tumor evolution across cancer types. Nat. Genet. 48, 238–244 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Bustamante, C.D., Wakeley, J., Sawyer, S. & Hartl, D.L. Directional selection and the site-frequency spectrum. Genetics 159, 1779–1788 (2001).

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Ray, N., Currat, M. & Excoffier, L. Intra-deme molecular diversity in spatially expanding populations. Mol. Biol. Evol. 20, 76–86 (2003).

    Article  CAS  PubMed  Google Scholar 

  24. Siegmund, K. & Shibata, D. At least two well-spaced samples are needed to genotype a solid tumor. BMC Cancer 16, 250 (2016).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Holsinger, K.E. & Weir, B.S. Genetics in geographically structured populations: defining, estimating and interpreting FST . Nat. Rev. Genet. 10, 639–650 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Durrett, R. Population genetics of neutral mutations in exponentially growing cancer cell populations. Ann. Appl. Probab. 23, 230–250 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  27. Kimura, M. Model of effectively neutral mutations in which selective constraint is incorporated. Proc. Natl. Acad. Sci. USA 76, 3440–3444 (1979).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Ohta, T. & Gillespie, J.H. Development of neutral and nearly neutral theories. Theor. Popul. Biol. 49, 128–142 (1996).

    Article  CAS  PubMed  Google Scholar 

  29. Rowan, A. et al. Refining molecular analysis in the pathways of colorectal carcinogenesis. Clin. Gastroenterol. Hepatol. 3, 1115–1123 (2005).

    Article  CAS  PubMed  Google Scholar 

  30. Qiao, Y. et al. SubcloneSeeker: a computational framework for reconstructing tumor clone structure for cancer variant interpretation and prioritization. Genome Biol. 15, 443 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  31. Li, B. & Li, J.Z. A general framework for analyzing tumor subclonality using SNP array and DNA sequencing data. Genome Biol. 15, 473 (2014).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Popic, V. et al. Fast and scalable inference of multi-sample cancer lineages. Genome Biol. 16, 91 (2015).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Ross-Innes, C.S. et al. Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma. Nat. Genet. 47, 1038–1046 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Zhang, J. et al. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science 346, 256–259 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. de Bruin, E.C. et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science 346, 251–256 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Johnson, B.E. et al. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343, 189–193 (2014).

    Article  CAS  PubMed  Google Scholar 

  37. Kim, H. et al. Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution. Genome Res. 25, 316–327 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Tajima, F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123, 585–595 (1989).

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Grossman, S.R. et al. A composite of multiple signals distinguishes causal variants in regions of positive selection. Science 327, 883–886 (2010).

    Article  CAS  PubMed  Google Scholar 

  40. Ostrow, S.L., Barshir, R., DeGregori, J., Yeger-Lotem, E. & Hershberg, R. Cancer evolution is associated with pervasive positive selection on globally expressed genes. PLoS Genet. 10, e1004239 (2014).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  41. Wu, C.-I., Wang, H.-Y., Ling, S. & Lu, X. The ecology and evolution of cancer: the ultra-microevolutionary process. Annu. Rev. Genet. 50, 347–369 (2016).

    Article  CAS  PubMed  Google Scholar 

  42. Messer, P.W. & Petrov, D.A. Population genomics of rapid adaptation by soft selective sweeps. Trends Ecol. Evol. 28, 659–669 (2013).

    Article  PubMed  Google Scholar 

  43. Lloyd, M.C. et al. Darwinian dynamics of intratumoral heterogeneity: not solely random mutations but also variable environmental selection forces. Cancer Res. 76, 3136–3144 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. McFarland, C.D., Korolev, K.S., Kryukov, G.V., Sunyaev, S.R. & Mirny, L.A. Impact of deleterious passenger mutations on cancer progression. Proc. Natl. Acad. Sci. USA 110, 2910–2915 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Marusyk, A. et al. Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity. Nature 514, 54–58 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Cleary, A.S., Leonard, T.L., Gestl, S.A. & Gunther, E.J. Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers. Nature 508, 113–117 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213–219 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  48. Ha, G. et al. TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data. Genome Res. 24, 1881–1893 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Waclaw, B. et al. A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity. Nature 525, 261–264 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Diaz, L.A. Jr. et al. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature 486, 537–540 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Bozic, I. et al. Accumulation of driver and passenger mutations during tumor progression. Proc. Natl. Acad. Sci. USA 107, 18545–18550 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Visvader, J.E. & Lindeman, G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 8, 755–768 (2008).

    Article  CAS  PubMed  Google Scholar 

  53. Wand, M.P. Data-based choice of histogram bin width. Am. Stat. 51, 59 (1997).

    Google Scholar 

  54. Bhatia, G., Patterson, N., Sankararaman, S. & Price, A.L. Estimating and interpreting FST: the impact of rare variants. Genome Res. 23, 1514–1521 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Kuhn, M. Building predictive models in R using the caret package. J. Stat. Softw. 28, 1–26 (2008).

    Article  Google Scholar 

Download references

Acknowledgements

This work was funded by awards from the NIH (R01CA182514), the Susan G. Komen Foundation (IIR13260750), and the Breast Cancer Research Foundation (BCRF-16-032) to C.C. and an award from the NIH (R01CA185016) to D.S. Z.H. is supported by an Innovative Genomics Initiative (IGI) Postdoctoral Fellowship. A.S. is supported by the Chris Rokos Fellowship. T.A.G. was supported by Cancer Research UK. This work was supported in part by NIH P30 CA124435 using the Genetics Bioinformatics Service Center within the Stanford Cancer Institute Shared Resource. The results are in part based upon data generated from the following studies: EGAD00001001394, EGAD00001000714, EGAD00001000900, EGAD00001000984, and EGAD00001001113. We thank members of the Curtis laboratory for helpful discussions.

Author information

Author notes

  1. Ruping Sun and Zheng Hu: These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Medicine, Stanford University School of Medicine, Stanford, California, USA

    Ruping Sun, Zheng Hu, Zhicheng Ma & Christina Curtis

  2. Department of Genetics, Stanford University School of Medicine, Stanford, California, USA

    Ruping Sun, Zheng Hu, Zhicheng Ma & Christina Curtis

  3. Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA

    Ruping Sun, Zheng Hu, Zhicheng Ma & Christina Curtis

  4. Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK

    Andrea Sottoriva

  5. Evolution and Cancer Laboratory, Barts Cancer Institute, Queen Mary University of London, London, UK

    Trevor A Graham

  6. Department of Biology, Stanford University, Stanford, California, USA

    Arbel Harpak

  7. Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, Oregon, USA

    Jared M Fischer

  8. Department of Pathology, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA

    Darryl Shibata

Authors
  1. Ruping Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zheng Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrea Sottoriva
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Trevor A Graham
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Arbel Harpak
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zhicheng Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jared M Fischer
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Darryl Shibata
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Christina Curtis
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

R.S., Z.H., and C.C. designed the study. R.S. analyzed and visualized the data and performed statistical analyses. Z.H. performed simulation studies. Z.M. and D.S. generated data. R.S., Z.H., and C.C. interpreted the data. A.S. and T.A.G. contributed to earlier analysis of the COAD data set. A.H. provided statistical advice. J.M.F. performed xenograft experiments. D.S. and C.C. provided reagents and data. C.C. supervised the study and wrote the manuscript with input from R.S. and Z.H. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Christina Curtis.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–36, Supplementary Tables 1–3 and Supplementary Note. (PDF 20850 kb)

Supplementary Table 4

SFS-derived ITH metrics for virtual tumors. (XLSX 303 kb)

Supplementary Table 5

SFS-derived ITH metrics and SVM-based classification of patient samples. (XLSX 18 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sun, R., Hu, Z., Sottoriva, A. et al. Between-region genetic divergence reflects the mode and tempo of tumor evolution. Nat Genet 49, 1015–1024 (2017). https://doi.org/10.1038/ng.3891

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.3891

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer